Sort
50,496 grants matching “lung cancer”
Improving Palliative Care for Patients with Cancer
$544,484Dartmouth College · R01 · FY2004 · CA
Tissue engineered organ-specific cancer metastasis model for cancer research
$544,475Andrew Zhuang Wang · Ut Southwestern Medical Center · R01 · FY2025 · CA
Tissue engineered organ-specific cancer metastasis model for cancer research
$544,475Andrew Zhuang Wang · Ut Southwestern Medical Center · R01 · FY2024 · CA
UCLA Pulmonary and Critical Care Medicine Training Program
$544,458Steven M. Dubinett · University Of California Los Angeles · T32 · FY2021 · HL
Increasing Participation in Cancer Clinical Trials
$544,405Carol P Somkin · Kaiser Foundation Research Institute · R01 · FY2008 · CA
Chemoprevention of Early Pulmonary Lesions in Mice
$544,396University Of Colorado Denver · R01 · FY2004 · CA
Implementation of Smoking Cessation Services within NCI NCORP Community Sites with Organized Lung Cancer Screening Programs
$544,303Kristie L Foley · Wake Forest University Health Sciences · R01 · FY2017 · CA
Targeting the ROR2/p-GSK3bS9 pathway to suppress metastasis in SMARCA4-deficient lung adenocarcinoma
$544,255David R Jones · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Sex-dependent Impairment of Nitric Oxide Signaling and Mitochondrial Metabolism in Radiation-Induced Cardio-Pulmonary Dysfunction
$544,248Barry London · University Of Iowa · U01 · FY2024 · AI
Sex-dependent Impairment of Nitric Oxide Signaling and Mitochondrial Metabolism in Radiation-Induced Cardio-Pulmonary Dysfunction
$544,248Barry London · University Of Iowa · U01 · FY2025 · AI
Translation of commensal bacteria mechanism for immunotherapy
$544,219Howard C Hang · Scripps Research Institute, The · R01 · FY2022 · CA
Translation of commensal bacteria mechanism for immunotherapy
$544,219Howard C Hang · Scripps Research Institute, The · R01 · FY2023 · CA
Project 2: Identifying Metabolic vulnerabilities and targets in cancers with mutations in hamartoma genes
$544,210David J. Kwiatkowski · Brigham And Women'S Hospital · P01 · FY2021 · CA
Project 2: Identifying Metabolic vulnerabilities and targets in cancers with mutations in hamartoma genes
$544,210David J. Kwiatkowski · Brigham And Women'S Hospital · P01 · FY2020 · CA
Laboratory of Genitourinary Cancer Pathogenesis Microscopy Core Facility
$544,131Yvona Ward · Division Of Basic Sciences - Nci · ZIC · FY2014 · CA
Analysis of Tumor Dynamics in Progression and Metastasis
$544,105Lewis A Chodosh · University Of Pennsylvania · U01 · FY2006 · CA
FRESH: Dual Home Screening for Lung Cancer Prevention
$544,043Ellen J Hahn · University Of Kentucky · R01 · FY2015 · ES
Investigating Max as a tumor suppressor gene in small cell lung cancer and other neuroendocrine tumors
$544,000Robert Neil Eisenman · Fred Hutchinson Cancer Center · R01 · FY2022 · CA
Investigating Max as a tumor suppressor gene in small cell lung cancer and other neuroendocrine tumors
$544,000Robert Neil Eisenman · Fred Hutchinson Cancer Center · R01 · FY2023 · CA
Novel radioimmunoconjugates for targeted alpha-particle therapy of metastatic prostatic cancer
$543,996Jiang He · University Of Virginia · R01 · FY2019 · CA
Interventions Against the Molecular Etiology of BMPR2-induced PAH
$543,969James D West · Vanderbilt University · R01 · FY2015 · HL
Genetic Loss-of-Function Studies of SETD2 in Kidney Tumorigenesis
$543,901Emily H Cheng · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
(PQ8) Predicting immune-related toxicity in the adjuvant melanoma setting with checkpoint inhibition
$543,889Iman Osman · New York University School Of Medicine · R01 · FY2019 · CA
Characterization of FGFR4 mutations in Rhabdomyosarcoma
$543,839Javed Khan · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Regulation and tumorigenesis of non-classical RAS oncoproteins - Resubmission
$543,820Pau Castel · New York University School Of Medicine · R01 · FY2024 · CA